Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 446

1.

Crizotinib, a MET inhibitor, prevents peritoneal dissemination in pancreatic cancer.

Takiguchi S, Inoue K, Matsusue K, Furukawa M, Teramoto N, Iguchi H.

Int J Oncol. 2017 May 11. doi: 10.3892/ijo.2017.3992. [Epub ahead of print]

PMID:
28498406
2.

The impact of carperitide usage on the cost of hospitalization and outcome in patients with acute heart failure: High value care vs. low value care campaign in Japan.

Mizuno A, Iguchi H, Sawada Y, Hurley M, Nomura H, Hayashi K, Tokuda Y, Watanabe S, Yoshikawa A.

Int J Cardiol. 2017 Apr 26. pii: S0167-5273(17)30779-9. doi: 10.1016/j.ijcard.2017.04.078. [Epub ahead of print]

PMID:
28476514
3.

Multiple-Hydrogen-Bond Approach to Uncommon Pd(III) Oxidation State: A Pd-Br Chain with High Conductivity and Thermal Stability.

Mian MR, Iguchi H, Takaishi S, Murasugi H, Miyamoto T, Okamoto H, Tanaka H, Kuroda SI, Breedlove BK, Yamashita M.

J Am Chem Soc. 2017 May 17;139(19):6562-6565. doi: 10.1021/jacs.7b02558. Epub 2017 May 8.

PMID:
28467845
4.

Efficacy and toxicity profiles of two chemoradiotherapies for stage II laryngeal cancer - a comparison between late course accelerated hyperfractionation (LCAHF) and conventional fractionation (CF).

Okazaki E, Matsushita N, Tashiro M, Shimatani Y, Ishii K, Hosono M, Oishi M, Teranishi Y, Iguchi H, Miki Y.

Acta Otolaryngol. 2017 Mar 16:1-5. doi: 10.1080/00016489.2017.1293295. [Epub ahead of print]

PMID:
28301268
5.

Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer.

Shindo Y, Hazama S, Suzuki N, Iguchi H, Uesugi K, Tanaka H, Aruga A, Hatori T, Ishizaki H, Umeda Y, Fujiwara T, Ikemoto T, Shimada M, Yoshimatsu K, Takenouchi H, Matsui H, Kanekiyo S, Iida M, Koki Y, Arima H, Furukawa H, Ueno T, Yoshino S, Fujita T, Kawakami Y, Nakamura Y, Oka M, Nagano H.

J Exp Clin Cancer Res. 2017 Feb 28;36(1):36. doi: 10.1186/s13046-017-0509-1.

6.

Photoresponsive Nanosheets of Polyoxometalates Formed by Controlled Self-Assembly Pathways.

Ishiba K, Noguchi T, Iguchi H, Morikawa MA, Kaneko K, Kimizuka N.

Angew Chem Int Ed Engl. 2017 Mar 6;56(11):2974-2978. doi: 10.1002/anie.201612473. Epub 2017 Feb 15.

PMID:
28199768
7.

Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer.

Ioka T, Komatsu Y, Mizuno N, Tsuji A, Ohkawa S, Tanaka M, Iguchi H, Ishiguro A, Kitano M, Satoh T, Yamaguchi T, Takeda K, Kida M, Eguchi K, Ito T, Munakata M, Itoi T, Furuse J, Hamada C, Sakata Y.

Br J Cancer. 2017 Feb 14;116(4):464-471. doi: 10.1038/bjc.2016.436. Epub 2017 Jan 12.

PMID:
28081543
8.

Rational and practical exfoliation of graphite using well-defined poly(3-hexylthiophene) for the preparation of conductive polymer/graphene composite.

Iguchi H, Higashi C, Funasaki Y, Fujita K, Mori A, Nakasuga A, Maruyama T.

Sci Rep. 2017 Jan 6;7:39937. doi: 10.1038/srep39937.

9.

Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology.

Shibata H, Kato S, Sekine I, Abe K, Araki N, Iguchi H, Izumi T, Inaba Y, Osaka I, Kato S, Kawai A, Kinuya S, Kodaira M, Kobayashi E, Kobayashi T, Sato J, Shinohara N, Takahashi S, Takamatsu Y, Takayama K, Takayama K, Tateishi U, Nagakura H, Hosaka M, Morioka H, Moriya T, Yuasa T, Yurikusa T, Yomiya K, Yoshida M.

ESMO Open. 2016 Mar 16;1(2):e000037. eCollection 2016. Review.

10.

Galacto-N-biose is neuroprotective against glutamate-induced excitotoxicity in vitro.

Shinoda Y, Nakajima Y, Iguchi H, Tatsumi S, Kitaoka M, Nakajima M, Takahashi T, Fujiwara Y, Furuichi T.

Eur J Pharmacol. 2016 Nov 15;791:711-717. doi: 10.1016/j.ejphar.2016.10.010. Epub 2016 Oct 8.

PMID:
27729249
11.

Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study.

Suzuki N, Hazama S, Iguchi H, Uesugi K, Tanaka H, Hirakawa K, Aruga A, Hatori T, Ishizaki H, Umeda Y, Fujiwara T, Ikemoto T, Shimada M, Yoshimatsu K, Shimizu R, Hayashi H, Sakata K, Takenouchi H, Matsui H, Shindo Y, Iida M, Koki Y, Arima H, Furukawa H, Ueno T, Yoshino S, Nakamura Y, Oka M, Nagano H.

Cancer Sci. 2017 Jan;108(1):73-80. doi: 10.1111/cas.13113. Epub 2016 Dec 19.

12.

Characterization of AvaR1, a butenolide-autoregulator receptor for biosynthesis of a Streptomyces hormone in Streptomyces avermitilis.

Sultan SP, Kitani S, Miyamoto KT, Iguchi H, Atago T, Ikeda H, Nihira T.

Appl Microbiol Biotechnol. 2016 Nov;100(22):9581-9591. Epub 2016 Aug 19.

PMID:
27541747
13.

Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as predictors of wound healing failure in head and neck reconstruction.

Maruyama Y, Inoue K, Mori K, Gorai K, Shimamoto R, Onitsuka T, Iguchi H, Okazaki M, Nakagawa M.

Acta Otolaryngol. 2017 Jan;137(1):106-110. Epub 2016 Aug 24.

PMID:
27553628
14.

Direct Observation of Ordered High-Spin-Low-Spin Intermediate States of an Iron(III) Three-Step Spin-Crossover Complex.

Li ZY, Ohtsu H, Kojima T, Dai JW, Yoshida T, Breedlove BK, Zhang WX, Iguchi H, Sato O, Kawano M, Yamashita M.

Angew Chem Int Ed Engl. 2016 Apr 18;55(17):5184-9. doi: 10.1002/anie.201511281. Epub 2016 Mar 17.

PMID:
26991042
15.

Low doses of the mycotoxin citrinin protect cortical neurons against glutamate-induced excitotoxicity.

Nakajima Y, Iguchi H, Kamisuki S, Sugawara F, Furuichi T, Shinoda Y.

J Toxicol Sci. 2016 Apr;41(2):311-9. doi: 10.2131/jts.41.311.

16.

Clinical Study of Extrapulmonary Head and Neck Tuberculosis: A Single-Institute 10-year Experience.

Oishi M, Okamoto S, Teranishi Y, Yokota C, Takano S, Iguchi H.

Int Arch Otorhinolaryngol. 2016 Jan;20(1):30-3. doi: 10.1055/s-0035-1565011. Epub 2015 Oct 8.

17.

A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer.

Ueno M, Okusaka T, Omuro Y, Isayama H, Fukutomi A, Ikeda M, Mizuno N, Fukuzawa K, Furukawa M, Iguchi H, Sugimori K, Furuse J, Shimada K, Ioka T, Nakamori S, Baba H, Komatsu Y, Takeuchi M, Hyodo I, Boku N.

Ann Oncol. 2016 Mar;27(3):502-8. doi: 10.1093/annonc/mdv603. Epub 2015 Dec 17.

18.
19.

Changes in jaw muscle activity and the physical properties of foods with different textures during chewing behaviors.

Iguchi H, Magara J, Nakamura Y, Tsujimura T, Ito K, Inoue M.

Physiol Behav. 2015 Dec 1;152(Pt A):217-24. doi: 10.1016/j.physbeh.2015.10.004. Epub 2015 Oct 9.

PMID:
26440319
20.

A Phase I study of MEDI-575, a PDGFRα monoclonal antibody, in Japanese patients with advanced solid tumors.

Murakami H, Ikeda M, Okusaka T, Inaba Y, Iguchi H, Yagawa K, Yamamoto N.

Cancer Chemother Pharmacol. 2015 Sep;76(3):631-9. doi: 10.1007/s00280-015-2832-6. Epub 2015 Jul 30.

PMID:
26223436

Supplemental Content

Loading ...
Support Center